November 14, 2011Date Released: 14 November 2011
CASE CCC IN THE NEWS
Why Men and Women React Differently to Cancer Gene
Champion of Integrative Oncology Brings International Conference
Cleveland Clinic, UH Testing Therapies on Deadly Brain Tumors
Cancer Vaccines That Could Save Lives
MARK YOUR CALENDARSCancer Center Seminar Series: Novel NFκB and STAT Signaling Pathways Present Novel Targets for Drug Development in Cancer
Friday, November 18
Please join us Friday, November 18at the next Cancer Center Seminar Series featuring George R. Stark, PhD, Staff and Distinguished Scientist in the Department of Molecular Genetics at the Cleveland Clinic Lerner Research Institute and Professor Emeritus in the Department of Genetics at Case Western Reserve University. In his presentation, Novel NFκB and STAT Signaling Pathways Present Novel Targets for Drug Development in Cancer, Dr. Stark will summarize recent progress and future plans on three topics:
This seminar is hosted by the Cancer Cell Signaling Program, but all are encouraged to attend. CME credit is available.Office of Cancer Centers Learning Series Webinar: Opportunity for CTSU Support for Collaborative Multi-Center Phase 2 Trials Led by NCI-Designated Cancer Centers and SPOREs
Please plan on participating in the next Office of Cancer Centers Learning Series Webinar on Monday, December 5from 2-3:30 pm. The presentation will describe an opportunity for Cooperative Group, NCI Designated Cancer Center, and Specialized Programs of Research Excellence (SPORE) investigators to develop clinical trial collaborations through discussions in NCI's Scientific Steering Committees. For clinical trial collaborations requiring multi-center coordinating support that is not otherwise available through existing networks, NCI will prioritize requests for in-kind coordination support through its Cancer Trials Support Unit (CTSU). Featured speaker Raymond A. Petryshyn, PhD, Program Director of the Coordinating Center for Clinical Trials, will discuss the type of support available, eligibility criteria and the evaluation process for CTSU applications.
FUNDING OPPORTUNITIESPancreatic Cancer Action Network-AACR Pathway to Leadership Grant
The AACR Pathway to Leadership Grant is designed to build future leaders in the pancreatic cancer research community by supporting a highly promising early-career scientist in his/her postdoctoral or clinical research fellowship through the transition to an independent researcher. Applicants must have started a postdoctoral or clinical research fellowship on or after July 2, 2007 (i.e., must be in the first five years of a fellowship at the start of the grant term).
Extended Deadline: November 29Robert Wood Johnson Foundation Clinical Scholars Program
The Robert Wood Johnson Foundation and the U.S. Department of Veterans Affairs collaborate to foster the development of physicians who will lead the transformation of Americans' health and health care through the Robert Wood Johnson Foundation Clinical Scholars program. These future leaders will conduct innovative research and work with communities, organizations, practitioners and policy-makers to address issues essential to the health and well-being of all Americans.
Deadline: February 29, 2012
ANNOUNCEMENTSVogelbaum and Peereboom Elected to Society for Neuro-Oncology Board of Directors
The following Cancer Center members were recently elected to the Society for Neuro-Oncology Board of Directors: Dr. Michael Vogelbaum, Vice President, and Dr. David Peereboom, Medical Oncology Representative. The Society for Neuro-Oncology is the largest international scientific and professional multidisciplinary society focused on the science and treatment of central nervous system tumors.NCI Releases Revised Best Practices for Biospecimen Resources
The NCI has announced the release of revised Best Practices for Biospecimen Resources. Originally released in 2007, this document identifies guiding principles defining state-of-the-science practices for biospecimen resources, promoting biospecimen and data quality, and supporting adherence to ethical and legal principles. This revised version incorporates more current and detailed recommendations, and responds to comments received from community stakeholders.
Major revisions include:
Like the 2007 release, this version of the NCI Best Practices underwent scrutiny by experts within NCI and throughout the NIH. A draft version of the revised document was posted online for public comment and all the input received was considered in the final version of the document.Friends of Cancer Research, with the Support of Over 25 Leading Advocacy Organizations, Releases Report Identifying Comparative Effectiveness Research (CER) Priority Studies in Cancer
Last week, Friends of Cancer Research released a new report, Expanding Comparative Effectiveness Research: Priority Areas in Oncology. The report is the outgrowth of the June 2011 Friends of Cancer Research conference that brought together key stakeholders from the entire cancer community. Over 40 initial topics were submitted for review and public input.
The report describes specific areas of CER that could begin to improve the field of oncology. It contains 13 potential comparative effectiveness research studies in oncology that were identified by leaders of the cancer community and the Friends Comparative Effectiveness Research Advisory Committee, that could begin to be addressed by public and private-sector funders of research. These entities include the publicly funded Patient-Centered Outcomes Research Institute, other government agencies, academic research institutions and the private sector.
**All events are open to anyone interested in attending
Skeletal Research Center
Hematology/Oncology Special Research Conference
Cancer Biology Special Seminar
Immunology Seminar Series
Hematology and Oncology Division Research Conference canceled
Immunology Visiting Professor Seminar Series
Molecular and Microbiology Seminar
Hematology/Oncology Fellows Conference canceled
Taussig Cancer Institute Grand Rounds
Cancer Center Seminar Series
Cancer Center Research in Progress Seminar
Case CCC Calendar
PREVIOUSLY ANNOUNCED OPPORTUNITIES
NCI Provocative Questions Project
HHMI Medical Research Fellows Program
NIH BULLETIN – Notices and Funding Opportunities
NIH Competitive Revision Applications for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (R01) (PAR-12-010)
NIH Competitive Revision Applications for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (U01) (PAR-12-011)
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.